News

Back Neuroscreen
 

The European research network Neuroscreen, which focuses on neurodegenerative disease was officially launched in Liège on January 24. Certain neurodegenerative diseases are not actually diagnosed until the patient has died. For scientists it’s clearly important to be able to detect such diseases in a reliable way. Five percent of those above 65 suffer from Alzheimer’s Disease, where the incubation period can take dozens of years, like the human version of the Creutzfeldt-Jacob Disease (CJD). The availability of diagnostic equipment would help those concerned with treating these diseases and this is the objective of the new network. The Center of Research for Prion Proteins at the University of Liège will be coordinating it. It will involve six European countries and has a budget of EUR 2,797,521 for three years.
http://www.ulg.ac.be/

(Source: Belga)

Copyright: Stafford Wadsworth, editor@meuse-rhine-journal.com